Johnson & Johnson (JNJ) is among the 14 Best Pharma Dividend Stocks to Buy in 2025. With a 63-year track record of increasing payouts, it’s a reliable Dividend King. Second-quarter results show the company generated $6.2 billion in free cash flow, covering its $6.1 billion in dividend obligations so far this year.

Despite a slightly lower free cash flow compared to last year, Johnson & Johnson (JNJ) offers a quarterly dividend of $1.30 per share with a 3.18% yield as of July 17. While it’s a solid investment, some believe AI stocks offer greater upside potential and less downside risk.

For those interested in other investment opportunities, check out the 13 Best Industrial Dividend Stocks to Buy Right Now and the 10 Best Passive Income Stocks to Buy Now. Disclosure: None.

Read more at Yahoo Finance: Johnson & Johnson’s (JNJ) Dividend Track Record: Reliability in Uncertain Times